Global Nuclear Medicine/Radiopharmaceuticals Market Insights and Forecast to 2027

Global Nuclear Medicine/Radiopharmaceuticals Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Nuclear Medicine/Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type
1.4.2 Diagnostic
1.4.3 Therapeutic
1.3 Market by Application
1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Estimates and Forecasts 2016-2027
2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Estimates and Forecasts 2016-2027
2.3 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Nuclear Medicine/Radiopharmaceuticals Regions by Sales
2.4.1 Global Top Nuclear Medicine/Radiopharmaceuticals Regions by Sales (2016-2021)
2.4.2 Global Top Nuclear Medicine/Radiopharmaceuticals Regions by Sales (2022-2027)
2.5 Global Top Nuclear Medicine/Radiopharmaceuticals Regions by Revenue
2.5.1 Global Top Nuclear Medicine/Radiopharmaceuticals Regions by Revenue (2016-2021)
2.5.2 Global Top Nuclear Medicine/Radiopharmaceuticals Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers
3.1.1 Global Top Nuclear Medicine/Radiopharmaceuticals Manufacturers by Sales (2016-2021)
3.1.2 Global Top Nuclear Medicine/Radiopharmaceuticals Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Nuclear Medicine/Radiopharmaceuticals Sales in 2020
3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Global Top Nuclear Medicine/Radiopharmaceuticals Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Nuclear Medicine/Radiopharmaceuticals Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Nuclear Medicine/Radiopharmaceuticals Revenue in 2020
3.3 Global Nuclear Medicine/Radiopharmaceuticals Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nuclear Medicine/Radiopharmaceuticals Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Type
4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Historical Sales by Type (2016-2021)
4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Forecasted Sales by Type (2022-2027)
4.1.3 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2027)
4.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type
4.2.1 Global Nuclear Medicine/Radiopharmaceuticals Historical Revenue by Type (2016-2021)
4.2.2 Global Nuclear Medicine/Radiopharmaceuticals Forecasted Revenue by Type (2022-2027)
4.2.3 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2016-2027)
4.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Type
4.3.1 Global Nuclear Medicine/Radiopharmaceuticals Price by Type (2016-2021)
4.3.2 Global Nuclear Medicine/Radiopharmaceuticals Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Application
5.1.1 Global Nuclear Medicine/Radiopharmaceuticals Historical Sales by Application (2016-2021)
5.1.2 Global Nuclear Medicine/Radiopharmaceuticals Forecasted Sales by Application (2022-2027)
5.1.3 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2027)
5.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application
5.2.1 Global Nuclear Medicine/Radiopharmaceuticals Historical Revenue by Application (2016-2021)
5.2.2 Global Nuclear Medicine/Radiopharmaceuticals Forecasted Revenue by Application (2022-2027)
5.2.3 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2016-2027)
5.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Application
5.3.1 Global Nuclear Medicine/Radiopharmaceuticals Price by Application (2016-2021)
5.3.2 Global Nuclear Medicine/Radiopharmaceuticals Price Forecast by Application (2022-2027)
6 North America
6.1 North America Nuclear Medicine/Radiopharmaceuticals Market Size by Type
6.1.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2027)
6.1.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2016-2027)
6.2 North America Nuclear Medicine/Radiopharmaceuticals Market Size by Application
6.2.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2027)
6.2.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2016-2027)
6.3 North America Nuclear Medicine/Radiopharmaceuticals Market Size by Country
6.3.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2027)
6.3.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Nuclear Medicine/Radiopharmaceuticals Market Size by Type
7.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2017-2027)
7.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2017-2027)
7.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Size by Application
7.2.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2017-2027)
7.2.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2017-2027)
7.3 Europe Nuclear Medicine/Radiopharmaceuticals Market Size by Country
7.3.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2017-2027)
7.3.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size by Type
8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type (2018-2027)
8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2018-2027)
8.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size by Application
8.2.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application (2018-2027)
8.2.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2018-2027)
8.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size by Region
8.3.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2018-2027)
8.3.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Nuclear Medicine/Radiopharmaceuticals Market Size by Type
9.1.1 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2019-2027)
9.1.2 Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2019-2027)
9.2 Latin America Nuclear Medicine/Radiopharmaceuticals Market Size by Application
9.2.1 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2019-2027)
9.2.2 Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2019-2027)
9.3 Latin America Nuclear Medicine/Radiopharmaceuticals Market Size by Country
9.3.1 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2019-2027)
9.3.2 Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size by Type
6.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2027)
6.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2016-2027)
6.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size by Application
6.2.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2027)
6.2.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2016-2027)
6.3 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size by Country
6.3.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2027)
6.3.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 China Isotope & Radiation
11.1.1 China Isotope & Radiation Corporation Information
11.1.2 China Isotope & Radiation Overview
11.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product Description
11.1.5 China Isotope & Radiation Related Developments
11.2 Dongcheng
11.2.1 Dongcheng Corporation Information
11.2.2 Dongcheng Overview
11.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Dongcheng Nuclear Medicine/Radiopharmaceuticals Product Description
11.2.5 Dongcheng Related Developments
11.3 Jaco
11.3.1 Jaco Corporation Information
11.3.2 Jaco Overview
11.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Jaco Nuclear Medicine/Radiopharmaceuticals Product Description
11.3.5 Jaco Related Developments
11.4 Ciaeriar
11.4.1 Ciaeriar Corporation Information
11.4.2 Ciaeriar Overview
11.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product Description
11.4.5 Ciaeriar Related Developments
11.5 Advanced Molecular-imaging Solution
11.5.1 Advanced Molecular-imaging Solution Corporation Information
11.5.2 Advanced Molecular-imaging Solution Overview
11.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product Description
11.5.5 Advanced Molecular-imaging Solution Related Developments
11.6 Shanghai Atom Kexing
11.6.1 Shanghai Atom Kexing Corporation Information
11.6.2 Shanghai Atom Kexing Overview
11.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product Description
11.6.5 Shanghai Atom Kexing Related Developments
11.1 China Isotope & Radiation
11.1.1 China Isotope & Radiation Corporation Information
11.1.2 China Isotope & Radiation Overview
11.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product Description
11.1.5 China Isotope & Radiation Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Nuclear Medicine/Radiopharmaceuticals Value Chain Analysis
12.2 Nuclear Medicine/Radiopharmaceuticals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nuclear Medicine/Radiopharmaceuticals Production Mode & Process
12.4 Nuclear Medicine/Radiopharmaceuticals Sales and Marketing
12.4.1 Nuclear Medicine/Radiopharmaceuticals Sales Channels
12.4.2 Nuclear Medicine/Radiopharmaceuticals Distributors
12.5 Nuclear Medicine/Radiopharmaceuticals Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nuclear Medicine/Radiopharmaceuticals Industry Trends
13.2 Nuclear Medicine/Radiopharmaceuticals Market Drivers
13.3 Nuclear Medicine/Radiopharmaceuticals Market Challenges
13.4 Nuclear Medicine/Radiopharmaceuticals Market Restraints
14 Key Findings in The Global Nuclear Medicine/Radiopharmaceuticals Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Diagnostic
Table 3. Major Manufacturers of Therapeutic
Table 4. Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Nuclear Medicine/Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 7. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 8. Global Nuclear Medicine/Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 9. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2022-2027)
Table 10. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 12. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2022-2027)
Table 14. Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers (2016-2021)
Table 16. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
Table 18. Nuclear Medicine/Radiopharmaceuticals Price by Manufacturers 2016-2021 (USD/Unit)
Table 19. Global Nuclear Medicine/Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Nuclear Medicine/Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals as of 2020)
Table 21. Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Offered
Table 23. Date of Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 26. Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 27. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2016-2021)
Table 28. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2022-2027)
Table 29. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2016-2021)
Table 32. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2022-2027)
Table 33. Nuclear Medicine/Radiopharmaceuticals Price by Type (2016-2021) & (USD/Unit)
Table 34. Global Nuclear Medicine/Radiopharmaceuticals Price Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 36. Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 37. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2016-2021)
Table 38. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2022-2027)
Table 39. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2016-2021)
Table 42. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2022-2027)
Table 43. Nuclear Medicine/Radiopharmaceuticals Price by Application (2016-2021) & (USD/Unit)
Table 44. Global Nuclear Medicine/Radiopharmaceuticals Price Forecast by Application (2022-2027) & (USD/Unit)
Table 45. North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 46. North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 47. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 50. North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 51. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 54. North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2022-2027) & (K Units)
Table 55. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 58. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 59. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 62. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 63. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 66. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2022-2027) & (K Units)
Table 67. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 105. China Isotope & Radiation Corporation Information
Table 106. China Isotope & Radiation Description and Major Businesses
Table 107. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 108. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product
Table 109. China Isotope & Radiation Recent Developments
Table 110. Dongcheng Corporation Information
Table 111. Dongcheng Description and Major Businesses
Table 112. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Dongcheng Nuclear Medicine/Radiopharmaceuticals Product
Table 114. Dongcheng Recent Developments
Table 115. Jaco Corporation Information
Table 116. Jaco Description and Major Businesses
Table 117. Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Jaco Nuclear Medicine/Radiopharmaceuticals Product
Table 119. Jaco Recent Developments
Table 120. Ciaeriar Corporation Information
Table 121. Ciaeriar Description and Major Businesses
Table 122. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product
Table 124. Ciaeriar Recent Developments
Table 125. Advanced Molecular-imaging Solution Corporation Information
Table 126. Advanced Molecular-imaging Solution Description and Major Businesses
Table 127. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product
Table 129. Advanced Molecular-imaging Solution Recent Developments
Table 130. Shanghai Atom Kexing Corporation Information
Table 131. Shanghai Atom Kexing Description and Major Businesses
Table 132. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product
Table 134. Shanghai Atom Kexing Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Nuclear Medicine/Radiopharmaceuticals Distributors List
Table 138. Nuclear Medicine/Radiopharmaceuticals Customers List
Table 139. Nuclear Medicine/Radiopharmaceuticals Market Trends
Table 140. Nuclear Medicine/Radiopharmaceuticals Market Drivers
Table 141. Nuclear Medicine/Radiopharmaceuticals Market Challenges
Table 142. Nuclear Medicine/Radiopharmaceuticals Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine/Radiopharmaceuticals Product Picture
Figure 2. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2020 & 2027
Figure 3. Diagnostic Product Picture
Figure 4. Therapeutic Product Picture
Figure 5. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2020 & 2027
Figure 6. Oncology
Figure 7. Thyroid
Figure 8. Cardiology
Figure 9. Nuclear Medicine/Radiopharmaceuticals Report Years Considered
Figure 10. Global Nuclear Medicine/Radiopharmaceuticals Sales 2016-2027 (K Units)
Figure 11. Global Nuclear Medicine/Radiopharmaceuticals Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Nuclear Medicine/Radiopharmaceuticals Revenue 2016-2027 (US$ Million)
Figure 13. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Figure 15. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2022-2027)
Figure 16. North America Nuclear Medicine/Radiopharmaceuticals Sales YoY (2016-2027) & (K Units)
Figure 17. North America Nuclear Medicine/Radiopharmaceuticals Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Nuclear Medicine/Radiopharmaceuticals Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Nuclear Medicine/Radiopharmaceuticals Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Nuclear Medicine/Radiopharmaceuticals Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Nuclear Medicine/Radiopharmaceuticals Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Nuclear Medicine/Radiopharmaceuticals Revenue in 2020
Figure 28. Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2027)
Figure 30. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2016-2027)
Figure 31. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2027)
Figure 32. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2016-2027)
Figure 33. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2027)
Figure 34. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2016-2027)
Figure 35. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2027)
Figure 36. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2016-2027)
Figure 37. North America Nuclear Medicine/Radiopharmaceuticals Sales Share by Country (2016-2027)
Figure 38. North America Nuclear Medicine/Radiopharmaceuticals Revenue Share by Country (2016-2027)
Figure 39. U.S. Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2027)
Figure 42. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2016-2027)
Figure 43. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2027)
Figure 44. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2016-2027)
Figure 45. Europe Nuclear Medicine/Radiopharmaceuticals Sales Share by Country (2016-2027)
Figure 46. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Share by Country (2016-2027)
Figure 47. Germany Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)
Figure 48. France Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Nuclear Medicine/Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)
Figure 50. Italy

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Nuclear Medicine market size was valued at US$ 6054.6 million in 2023. With growing demand in downstream market, the Nuclear Medicine is forecast to a readjusted size of US$ 10160 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Nuclear Medicine market. Nuclear Medicine are expected to show stable growth in the future market. However, product different......

Global Nuclear Imaging Equipment Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 138

Nuclear medicine uses a special gamma camera and single-photon emission-computed tomography (SPECT) imaging techniques. The gamma camera records the energy emissions from the radiotracer in your body and converts it into an image. The gamma camera itself does not emit any radiation. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each seg......

Global Nuclear Imaging Equipment Professional Survey Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 107

Nuclear medicine uses a special gamma camera and single-photon emission-computed tomography (SPECT) imaging techniques. The gamma camera records the energy emissions from the radiotracer in your body and converts it into an image. The gamma camera itself does not emit any radiation. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each seg......

Global Gamma Camera Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 104

Market Overview of Global Gamma Camera market: According to our latest research, the global Gamma Camera market looks promising in the next 5 years. As of 2022, the global Gamma Camera market was estimated at USD 622.4 million, and it's anticipated to reach USD 742.27 million in 2028, with a CAGR of 2.98% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Gamma Camera market, with ......

Global Nuclear Imaging Equipment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Nuclear Imaging Equipment market: According to our latest research, the global Nuclear Imaging Equipment market looks promising in the next 5 years. As of 2022, the global Nuclear Imaging Equipment market was estimated at USD 3813.05 million, and it's anticipated to reach USD 5077.36 million in 2028, with a CAGR of 4.89% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Nuclear Medicine Equipment Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 93

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nuclear Medicine Equipment market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Philips - Siemens - Digirad - Mediso Medical Imaging Systems - Toshiba - Bozlu - Neusoft - Compañía Mexicana - SurgicE......

Global Nuclear Imaging Systems Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 97

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nuclear Imaging Systems market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - GE Healthcare - Siemens Healthcare - Philips Healthcare - Canon Medical Systems - Hitachi Medical - Digirad Corporation - DDD-Diagnosti......

Global Nuclear Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 105

Market Overview of Global Nuclear Medicine market: According to our latest research, the global Nuclear Medicine market looks promising in the next 5 years. As of 2022, the global Nuclear Medicine market was estimated at USD 4471.65 million, and it's anticipated to reach USD 7074.48 million in 2028, with a CAGR of 7.95% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nuclear Med......

Global Nuclear Imaging Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Nov-2023        Price: US 3380 Onwards        Pages: 104

Market Overview of Global Nuclear Imaging market: According to our latest research, the global Nuclear Imaging market looks promising in the next 5 years. As of 2022, the global Nuclear Imaging market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nuclear Imaging market, wi......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs